valrubicin

pharmaceutical drug

Facts

12 properties
Instance of
type of chemical entity
Has use
medication
Active ingredient in
Valstar
Canonical SMILES
CCCCC(=O)OCC(=O)C1(CC(C2=C(C3=C(C(=C2C1)O)C(=O)C4=C(C3=O)C(=CC=C4)OC)O)OC5CC(C(C(O5)C)O)NC(=O)C(F)(F)F)O
Chemical formula
C₃₄H₃₆F₃NO₁₃
Isomeric SMILES
CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C3=C(C1)C(O)=C4C(=O)C5=CC=CC(OC)=C5C(=O)C4=C3O
Mass
723.213875 Da
Medical condition treated
bladder cancer
NCI Thesaurus ID
C1340
Pregnancy category
US pregnancy category C
Subject has role
topoisomerase inhibitor, antineoplastic, topoisomerase II inhibitor
🏷️ Also known as
en 2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-({2,3,6-trideoxy-3-[(trifluoroacetyl)amino]hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethyl pentanoate en (8S, 10S)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-(2,2,2-trifluoroacetamido)-α-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione 8²-valerate en valrubicin en Valstar ja バルルビシン ro Valrubicină
🔖 Identifiers · 25
ATC code
L01DB09
CAS Registry Number
56124-62-0
ChEBI ID
135876
ChEMBL ID
CHEMBL20225
ChemSpider ID
38088
DSSTOX compound identifier
DTXCID7026497
DSSTox substance ID
DTXSID9046497
DrugBank ID
DB00385
DrugCentral ID
2805
EC number
680-664-1
ECHA Substance Infocard ID
100.205.793
Freebase ID
/m/07cqhf
Show all 25 identifiers +13
HSDB ID
7288
MeSH descriptor ID
C016163
Microsoft Academic ID (discontinued)
2778368998
NDF-RT ID
N0000148597
NSC number
246131
Probes And Drugs ID
PD014197
PubChem CID
454216
RxNorm CUI
31435
SureChEMBL ID
12824
UniChem compound ID
124816

Report an error or request removal Lineage (PROV-JSON)

🔗 Connections
Subject has role 2
Has use 1
Medical condition treated 1
← Drug or therapy used for treatment 1
Press Enter · cited answer in seconds

Summary

valrubicin is a type of chemical entity[1]. valrubicin is a type of 2-Oxo-2-[2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-({2,3,6-trideoxy-3-[(2,2,2-trifluoro-1-hydroxyethylidene)amino]hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethyl pentanoate[2].

Key Facts

  • Canonical SMILES: CCCCC(=O)OCC(=O)C1(CC(C2=C(C3=C(C(=C2C1)O)C(=O)C4=C(C3=O)C(=CC=C4)OC)O)OC5CC(C(C(O5)C)O)NC(=O)C(F)(F)F)O[3]
  • Chemical formula: C₃₄H₃₆F₃NO₁₃[4]
  • Has use: medication[5]
  • NCI Thesaurus ID: C1340[6]
  • Isomeric SMILES: CCCCC(=O)OCC(=O)[C@@]1(O)CC@HC3=C(C1)C(O)=C4C(=O)C5=CC=CC(OC)=C5C(=O)C4=C3OC@HC3=C(C1)C(O)=C4C(=O)C5=CC=CC(OC)=C5C(=O)C4=C3O">[7]
  • Mass: 723.213875 dalton[8]
  • Medical condition treated: bladder cancer[9]
  • Subject has role: topoisomerase inhibitor[10], antineoplastic[11], topoisomerase II inhibitor[12]
  • Pregnancy category: US pregnancy category C[13]
  • Active ingredient in: Valstar[14]

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [3] ↑ . wikidata.org.
  2. [4] ↑ . PubChem. Retrieved . wikidata.org.
  3. [2] ↑ . wikidata.org.
  4. [5] ↑ . DrugBank. wikidata.org.
  5. [6] ↑ . Global Substance Registration System. Retrieved . wikidata.org.
  6. [7] ↑ . Global Substance Registration System. Retrieved . wikidata.org.
  7. [8] ↑ . PubChem. Retrieved . wikidata.org.
  8. [9] ↑ . NDF-RT. Retrieved . wikidata.org.
  9. [10] ↑ . NDF-RT. Retrieved . wikidata.org.
  10. [11] ↑ . Medical Subject Headings. Retrieved . wikidata.org.
  11. [12] ↑ . Medical Subject Headings. Retrieved . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . RxNorm. Retrieved . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). valrubicin. Retrieved November 17, 2026, from https://4ort.xyz/entity/valrubicin
MLA “valrubicin.” 4ort.xyz Knowledge Graph, 4ort.xyz, 17 Nov. 2026, https://4ort.xyz/entity/valrubicin.
BibTeX @misc{4ortxyz_valrubicin_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{valrubicin}}, year = {2026}, url = {https://4ort.xyz/entity/valrubicin}, note = {Accessed: 2026-11-17}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): valrubicin — https://4ort.xyz/entity/valrubicin (retrieved 2026-11-17)

Canonical URL: https://4ort.xyz/entity/valrubicin · Last refreshed:

Edit History

Rolling log of changes to this entity's Wikidata record. Values shown reflect the current state of each edited property — follow the history link to see the precise diff for any edit.

  1. 15d ago · Elivan da Silva · 2026-11-04 view diff on Wikidata ↗
    Medical condition treated → bladder cancer
    Instance of → type of chemical entity
    Subject has role → topoisomerase inhibitor, antineoplastic, topoisomerase II inhibitor
    Has use → medication
    + 4 other properties edited (see Wikidata diff for full list)
    "Added [pt] label: valrubicina, #temporary_batch_1793784355819"
Live feed via Wikidata EventStreams. New edits appear within minutes of being made on Wikidata.